1. EGR-1 acts as a transcriptional activator of KLK7 under IL-13 stimulation.
- Author
-
Yeo H, Ahn SS, Lee JY, and Shin SY
- Subjects
- Animals, Dermatitis, Atopic genetics, Dermatitis, Atopic metabolism, Dermatitis, Atopic pathology, Disease Models, Animal, Early Growth Response Protein 1 antagonists & inhibitors, Early Growth Response Protein 1 deficiency, Early Growth Response Protein 1 genetics, Gene Knockdown Techniques, HaCaT Cells, Humans, Kallikreins metabolism, Keratinocytes metabolism, Keratinocytes pathology, MAP Kinase Signaling System, Mice, Mice, Knockout, Mutagenesis, Site-Directed, Promoter Regions, Genetic, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Small Interfering genetics, Trans-Activators antagonists & inhibitors, Trans-Activators genetics, Trans-Activators metabolism, Early Growth Response Protein 1 metabolism, Interleukin-13 metabolism, Kallikreins genetics
- Abstract
Kallikrein-related peptidase 7 (KLK7) is a chymotrypsin-like serine peptidase that plays a crucial role in regulating skin desquamation. KLK7 expression is highly upregulated in atopic dermatitis (AD) skin lesions in both humans and mice. Th2-lymphocyte-derived cytokines, including interleukin (IL)-4 and IL-13, have been shown to promote KLK7 expression in keratinocytes in patients with AD. However, the molecular mechanism underlying KLK7 expression remains poorly understood. Here, we demonstrated that the EGR-1-binding sequence (EBS) in the promoter region of KLK7 played a crucial role in IL-13-induced KLK7 transcription. Disruption of the EBS induced by a point mutation inhibited IL-13-induced KLK7 promoter activity. EGR-1 was shown to directly bind to the EBS, and EGR1 knockdown with shRNA abrogated IL-13-induced KLK7 expression. Using Egr1 knockout mice, we showed that Egr-1 was necessary for KLK7 expression in AD-like lesions induced by the repeated topical application of 2,4-dinitrobenzene on the dorsal skin of mice. We also demonstrated that the ERK1/2 mitogen-activated protein kinase (MAPK) pathway was responsible for EGR-1-dependent KLK7 transcription in response to IL-13 stimulation. Our findings delineate a signaling pathway that contributes to the regulation of KLK7 expression through the IL13-ERK MAPK-EGR1 signaling axis., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF